help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Polosa, R.
Right arrow Articles by Mistretta, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Polosa, R.
Right arrow Articles by Mistretta, A.

Am. J. Respir. Crit. Care Med., Vol 151, No. 3, Mar 1995, 624-629.

Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma

R Polosa, WH Ng, N Crimi, C Vancheri, ST Holgate, MK Church and A Mistretta
Istituto Malattie Apparato Respiratorio, Universita di Catania, Italy.

Preformed and newly generated mediators released from airway mast cells may play a role in adenosine-induced bronchoconstriction. To investigate the possible role of mast-cell-derived mediator release in mediating bronchoconstriction induced by adenosine 5'-monophosphate (AMP), we have examined the fluid obtained by bronchoalveolar lavage for inflammatory mediators and markers of airway permeability immediately after instillation of AMP directly into an airway segment of 10 asthmatic subjects. Eight subjects completed the protocol. When compared with the saline-challenged segment, the response to endobronchial stimulation with AMP was characterized by a prompt reduction in airway caliber paralleled by a significant rise in PGD2, histamine, and tryptase levels in the lavage fluid. After AMP challenge, the median (range) concentration for PGD2 increased from 36 to 205 pg/ml (p = 0.006), for histamine from 184 to 433 pg/ml (p = 0.018), and for tryptase from 0.30 to 0.54 ng/ml (p = 0.013). In addition, a small but significant rise in albumin levels (from 27.8 to 36.1 micrograms/ml; p = 0.031) was detected after endobronchial challenge with AMP. These findings indicate that adenosine-induced responses may be initiated by the acute release of mast-cell-derived mediators, including PGD2, histamine, and tryptase.


This article has been cited by other articles:


Home page
J. Immunol.Home page
Y. Fukuoka, H.-Z. Xia, L. B. Sanchez-Munoz, A. L. Dellinger, L. Escribano, and L. B. Schwartz
Generation of Anaphylatoxins by Human {beta}-Tryptase from C3, C4, and C5
J. Immunol., May 1, 2008; 180(9): 6307 - 6316.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. J. Mustafa, A. Nadeem, M. Fan, H. Zhong, L. Belardinelli, and D. Zeng
Effect of a Specific and Selective A2B Adenosine Receptor Antagonist on Adenosine Agonist AMP and Allergen-Induced Airway Responsiveness and Cellular Influx in a Mouse Model of Asthma
J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1246 - 1251.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. Prieto, I. Reig, R. Rojas, A. Ferrer, and J. Domenech
The effect of challenge method on sensitivity and reactivity to adenosine 5'-monophosphate in subjects with suspected asthma.
Chest, November 1, 2006; 130(5): 1448 - 1453.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
H. Zhong, Y. Wu, L. Belardinelli, and D. Zeng
A2B Adenosine Receptors Induce IL-19 from Bronchial Epithelial Cells, Resulting in TNF-{alpha} Increase
Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 587 - 592.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
G. Cruse, D. Kaur, W. Yang, S. M. Duffy, C. E. Brightling, and P. Bradding
Activation of human lung mast cells by monomeric immunoglobulin E
Eur. Respir. J., May 1, 2005; 25(5): 858 - 863.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. J. Oldenburg and S. J. Mustafa
Involvement of Mast Cells in Adenosine-Mediated Bronchoconstriction and Inflammation in an Allergic Mouse Model
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 319 - 324.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. Prieto, C. Badiola, J. Cortijo, C. Perez-Frances, V. Gutierrez, and A. Lanuza
Phenol-Containing Saline Solution as a Diluent for Adenosine 5'-Monophosphate in Bronchial Challenge Testing
Chest, January 1, 2005; 127(1): 125 - 130.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
H. Zhong, L. Belardinelli, T. Maa, and D. Zeng
Synergy between A2B Adenosine Receptors and Hypoxia in Activating Human Lung Fibroblasts
Am. J. Respir. Cell Mol. Biol., January 1, 2005; 32(1): 2 - 8.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Ryzhov, A. E. Goldstein, A. Matafonov, D. Zeng, I. Biaggioni, and I. Feoktistov
Adenosine-Activated Mast Cells Induce IgE Synthesis by B Lymphocytes: An A2B-Mediated Process Involving Th2 Cytokines IL-4 and IL-13 with Implications for Asthma
J. Immunol., June 15, 2004; 172(12): 7726 - 7733.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
I.E. Zuhlke, F. Kanniess, K. Richter, D. Nielsen-Gode, S. Bohme, R.A. Jorres, and H. Magnussen
Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD
Eur. Respir. J., December 1, 2003; 22(6): 926 - 930.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. Prieto, L. Bruno, V. Gutierrez, S. Uixera, C. Perez-Frances, A. Lanuza, and A. Ferrer
Airway Responsiveness to Adenosine 5'-Monophosphate and Exhaled Nitric Oxide Measurements: Predictive Value as Markers for Reducing the Dose of Inhaled Corticosteroids in Asthmatic Subjects
Chest, October 1, 2003; 124(4): 1325 - 1333.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Q. Gu, T. Ruan, J.-L. Hong, N. Burki, and L.-Y. Lee
Selected Contribution: Hypersensitivity of pulmonary C fibers induced by adenosine in anesthetized rats
J Appl Physiol, September 1, 2003; 95(3): 1315 - 1324.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. L. Tilley, M. Tsai, C. M. Williams, Z.-S. Wang, C. J. Erikson, S. J. Galli, and B. H. Koller
Identification of A3 Receptor- and Mast Cell-Dependent and -Independent Components of Adenosine-Mediated Airway Responsiveness in Mice
J. Immunol., July 1, 2003; 171(1): 331 - 337.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
G.F. Joos and B. O'Connor
Indirect airway challenges
Eur. Respir. J., June 1, 2003; 21(6): 1050 - 1068.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. Prieto, V. Gutierrez, S. Uixera, and J. M. Berto
Effect of Cigarette Smoking on Airway Responsiveness to Adenosine 5'-Monophosphate in Subjects With Allergic Rhinitis
Chest, April 1, 2003; 123(4): 993 - 997.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. Prieto, V. Gutierrez, V. Torres, S. Uixera, and J. Marin
Effect of Salmeterol on Seasonal Changes in Airway Responsiveness and Exhaled Nitric Oxide in Pollen-Sensitive Asthmatic Subjects*
Chest, September 1, 2002; 122(3): 798 - 805.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. Prieto, S. Uixera, V. Gutierrez, and L. Bruno
Modifications of Airway Responsiveness to Adenosine 5'-Monophosphate and Exhaled Nitric Oxide Concentrations After the Pollen Season in Subjects With Pollen-Induced Rhinitis*
Chest, September 1, 2002; 122(3): 940 - 947.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R. Polosa
Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease
Eur. Respir. J., August 1, 2002; 20(2): 488 - 496.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
R Polosa, S Rorke, and S T Holgate
Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease
Thorax, July 1, 2002; 57(7): 649 - 654.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. Prieto, V. Gutierrez, and S. Uixera
Exhaled Nitric Oxide and Bronchial Responsiveness to Adenosine 5'-Monophosphate in Subjects With Allergic Rhinitis*
Chest, June 1, 2002; 121(6): 1853 - 1859.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. DE MEER, D. HEEDERIK, and D. S. POSTMA
Bronchial Responsiveness to Adenosine 5'-Monophosphate (AMP) and Methacholine Differ in Their Relationship with Airway Allergy and Baseline FEV1
Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 327 - 331.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. T. Holgate
Adenosine: a key effector molecule of asthma or just another mediator?
Am J Physiol Lung Cell Mol Physiol, February 1, 2002; 282(2): L167 - L168.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. TAUBE, O. HOLZ, M. MUCKE, R. A. JORRES, and H. MAGNUSSEN
Airway Response to Inhaled Hypertonic Saline in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1810 - 1815.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Van Den BERGE, H. A. M. KERSTJENS, R. J. MEIJER, D. M. DE REUS, G. H. KOETER, H. F. KAUFFMAN, and D. S. POSTMA
Corticosteroid-induced Improvement in the PC20 of Adenosine Monophosphate Is More Closely Associated with Reduction in Airway Inflammation than Improvement in the PC20 of Methacholine
Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1127 - 1132.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Van Den BERGE, R. J. MEIJER, H. A. M. KERSTJENS, D. M. de REUS, G. H. KOETER, H. F. KAUFFMAN, and D. S. POSTMA
PC20 Adenosine 5'-Monophosphate Is More Closely Associated with Airway Inflammation in Asthma Than PC20 Methacholine
Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1546 - 1550.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
L. Prieto, V. Gutierrez, J. Linana, and J. Marin
Bronchoconstriction induced by inhaled adenosine 5'-monophosphate in subjects with allergic rhinitis
Eur. Respir. J., January 1, 2001; 17(1): 64 - 70.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. M. WILSON, L. C. ORR, E. J. SIMS, O. J. DEMPSEY, and B. J. LIPWORTH
Antiasthmatic Effects of Mediator Blockade versus Topical Corticosteroids in Allergic Rhinitis and Asthma
Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1297 - 1301.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. M. van den TOORN, J.-B. PRINS, S. E. OVERBEEK, H. C. HOOGSTEDEN, and J. C. de JONGSTE
Adolescents in Clinical Remission of Atopic Asthma Have Elevated Exhaled Nitric Oxide Levels and Bronchial Hyperresponsiveness
Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 953 - 957.
[Abstract] [Full Text]


Home page
ThoraxHome page
M. ENNIS, P. FORSYTHE, L. P A MCGARVEY, L. G HEANEY, J. MACMAHON;, and R POLOSA
Nasal provocation with AMP
Thorax, November 1, 1999; 54(11): 1050 - 1050.
[Full Text]


Home page
ThoraxHome page
R Polosa, C Pagano, G Prosperini, J L Low, D Dokic, M K Church, and N Crimi
Histamine release upon adenosine 5'-monophosphate (AMP) nasal provocation in allergic subjects
Thorax, March 1, 1999; 54(3): 230 - 233.
[Abstract] [Full Text]


Home page
J. Appl. Physiol.Home page
I. T. Lauredo, J. R. Sabater, A. Ahmed, Y. Botvinnikova, and W. M. Abraham
Mechanism of pyocyanin- and 1-hydroxyphenazine-induced lung neutrophilia in sheep airways
J Appl Physiol, December 1, 1998; 85(6): 2298 - 2304.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. J. Barnes, K. F. Chung, and C. P. Page
Inflammatory Mediators of Asthma: An Update
Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
I. Feoktistov and I. Biaggioni
Adenosine A2B Receptors
Pharmacol. Rev., December 1, 1997; 49(4): 381 - 402.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1995 American Thoracic Society